EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity
Vivani Medical, Inc. (NASDAQ:VANI) announced the administration of its first GLP-1 (exenatide, NPM-115) implant in the ...
Le Lézard26m
Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults
Vivani Medical, Inc. ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the successful administration of its ...
The Ozempic workout? How gyms and trainers are catering to a new group of exercisers
With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...
New York Utility Company May Raise Bills to Cover Employees' Ozempic
Customers can expect a rate hike up to 14 percent as employee welfare costs surge related to Ozempic and drugs like it.
The Healthy @Reader's Digest on MSN18h
How I Knew I Had Pre-Diabetes: A Patient’s Story of Reversing Diabetes Before It Kicked In
Prediabetes affects almost 100 million Americans, but many don't know it. A patient shares their wake-up call, while a doctor ...